首页> 外文期刊>Annals of diagnostic pathology >Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
【24h】

Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.

机译:人端粒酶逆转录酶在大肠肿瘤中的表达:与免疫组织化学表达和临床病理特征的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Human telomerase reverse transcriptase (hTERT) proteins in colorectal cancer investigated in several studies, but to our knowledge, hTERT expression has not been evaluated in all of colorectal tumors, including hyperplastic polyps (HPs), adenomas, and carcinomas, on paraffin-embedded tissue sections. The aim of the present study is to investigate immunohistochemical hTERT expression and its relationship with the clinicopathologic features in a spectrum of colorectal tumors. In this study, hTERT expression was determined in HP (n = 20), adenomatous polyp (AP) (n = 20), colorectal adenocarcinomas (n = 20), and normal mucosa (n = 20) by immunohistochemical method. The findings were correlated with the clinicopathologic features. The staining level of hTERT in adenomas and carcinomas was significantly higher than in normal tissues (P < .05). There was also significant difference between HP and AP (P < .05). Level of hTERT in carcinomas was higher than in adenomas, but the difference was of no statistical significance (P > .05). There was no significant association of hTERT expression in cancerous, precancerous, or normal mucosa related to clinicopathologic parameters including age, sex, and size of lesion, (P > .05), but only association with histologic grade for carcinoma was found (P < .05). Levels of hTERT by immunohistochemistry demonstrated that the expression of hTERT was very little in normal mucosa and HP, moderate in AP, and highest in carcinoma. Thereby, hTERT expression may use the aggressiveness of the colorectal tumors as a marker, but it is not related to clinicopathologic data.
机译:人类结直肠癌中的人类端粒酶逆转录酶(hTERT)蛋白已在多项研究中进行了研究,但据我们所知,尚未在石蜡包埋的组织中所有结直肠肿瘤(包括增生性息肉(HPs),腺瘤和癌)中评估hTERT的表达。部分。本研究的目的是调查大肠肿瘤中免疫组化hTERT的表达及其与临床病理特征的关系。在这项研究中,通过免疫组织化学方法确定了hTERT在HP(n = 20),腺瘤性息肉(AP)(n = 20),结直肠腺癌(n = 20)和正常黏膜(n = 20)中的表达。这些发现与临床病理特征相关。腺瘤和癌组织中hTERT的染色水平显着高于正常组织(P <.05)。 HP和AP之间也存在显着差异(P <.05)。癌中hTERT水平高于腺瘤,但差异无统计学意义(P> .05)。在癌变,癌前或正常黏膜中,hTERT表达与临床病理参数(包括年龄,性别和病变大小)无显着相关性(P> .05),但仅与癌的组织学分级相关(P < .05)。免疫组织化学检测hTERT的水平表明,hTERT的表达在正常粘膜和HP中很少,在AP中中等,在癌中最高。因此,hTERT表达可以将结直肠肿瘤的侵袭性用作标记,但与临床病理数据无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号